JPRN-UMIN000008588已完成未知
Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularization - Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularization
Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele0 个研究点目标入组 50 人开始时间: 2012年8月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) intraocular surgery of any kind within six months of the day of injection, 2) any other ocular disease that could compromise vision in the study eye, 3) ocular hypertension or glaucoma 4) uncontrolled systemic hypertension; peripheral vascular disease and history of thromboembolism, ischemic heart disease or stroke.
研究者
相似试验
已完成
2 期
Comparison of Intravitreal Bevacizumab and Triamcinolone with Placebo in Acute Nonarteritic Anterior Ischemic Optic NeuropathyAnterior Ischemic of Optic Nerve.Disorders of optic nerve, not elsewhere classifiedIRCT1138901221180N13Ophthalmic Research Center16
已完成
不适用
Comparison of intravitreal ranibizumab injection with or without tissue plasminogen activator in the treatment of type 2 choroidal neovascularizationeovascular age-related macular degenerationJPRN-UMIN000017081Department of Ophthalmology and Visual Science Nagoya City University Graduate School of Medical Sciences20
已完成
不适用
Intra ocular injection of Bevacizumab and Triamcinolone for diabetic visual loss.CTRI/2014/09/005070ethradhama Superspeciality Eye Hospita15
尚未招募
不适用
The response of intravitreal bevacizumab in the treatment of intraocular neovascularizatioOcular neovascularizationJPRN-UMIN000009389Osaka University Hospital80
尚未招募
不适用
The response of intravitreal bevacizumab in the treatment of macular edemamacular edemaJPRN-UMIN000009390Osaka University Hospital180